Form D · Manufacturing

EntoGenetics Inc.

Charlotte, NC · CIK 0001546618

Offering snapshot reported Jul 18, 2013 · SEC filing

Reported sold
$540K
Offering amount: $3M
Investors reported
28
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 3, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$270K$540KApr 13, 2012: $9,500.00Apr 13, 2012Jul 18, 2013: $540,220.00Jul 18, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$9,500 → $540,220
  • Reported investors2 → 28

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 18, 2013Amendment$540,220$530,720vs Apr 13, 201228SEC filing
Apr 13, 2012Initial$9,500No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$7.5K (estimated)
Form D file number
021-176727

Source: Form D, filed Jul 18, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Bogin Director
David Brigham Director, Executive
Teresa Brigham Executive
Nicholas Rose Director, Executive

Issuer details

Industry: Manufacturing (See others in industry)

Address:
7125 Colleton Place
Charlotte, NC, 28270